参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/20 | 1,116 | 1,117 | 1,083 | 1,083 | -30 | -2.7% | 2,226,300 |
2023/03/17 | 1,084 | 1,120 | 1,076 | 1,113 | +42 | +3.9% | 3,470,100 |
2023/03/16 | 1,048 | 1,079 | 1,045 | 1,071 | +17 | +1.6% | 2,261,100 |
2023/03/15 | 1,041 | 1,060 | 1,041 | 1,054 | +19 | +1.8% | 1,430,000 |
2023/03/14 | 1,035 | 1,038 | 1,025 | 1,035 | -13 | -1.2% | 1,740,300 |
2023/03/13 | 1,057 | 1,058 | 1,041 | 1,048 | -13 | -1.2% | 1,315,100 |
2023/03/10 | 1,064 | 1,070 | 1,060 | 1,061 | -6 | -0.6% | 1,653,800 |
2023/03/09 | 1,058 | 1,071 | 1,055 | 1,067 | +5 | +0.5% | 1,076,700 |
2023/03/08 | 1,049 | 1,067 | 1,048 | 1,062 | +11 | +1% | 1,417,800 |
2023/03/07 | 1,047 | 1,064 | 1,043 | 1,051 | +2 | +0.2% | 1,762,600 |
2023/03/06 | 1,043 | 1,053 | 1,038 | 1,049 | +9 | +0.9% | 2,130,300 |
2023/03/03 | 1,011 | 1,042 | 1,009 | 1,040 | +24 | +2.4% | 4,115,800 |
2023/03/02 | 1,019 | 1,029 | 1,013 | 1,016 | -6 | -0.6% | 2,986,400 |
2023/03/01 | 1,036 | 1,037 | 1,021 | 1,022 | -18 | -1.7% | 1,847,300 |
2023/02/28 | 1,050 | 1,053 | 1,037 | 1,040 | -14 | -1.3% | 1,979,800 |
2023/02/27 | 1,052 | 1,061 | 1,045 | 1,054 | +3 | +0.3% | 1,861,700 |
2023/02/24 | 1,043 | 1,056 | 1,039 | 1,051 | +17 | +1.6% | 2,144,700 |
2023/02/22 | 1,047 | 1,050 | 1,026 | 1,034 | -8 | -0.8% | 1,868,800 |
2023/02/21 | 1,025 | 1,046 | 1,019 | 1,042 | +36 | +3.6% | 2,690,800 |
2023/02/20 | 1,003 | 1,007 | 999 | 1,006 | +11 | +1.1% | 845,600 |
2023/02/17 | 991 | 998 | 989 | 995 | -6 | -0.6% | 2,018,000 |
2023/02/16 | 999 | 1,001 | 993 | 1,001 | +2 | +0.2% | 1,741,300 |
2023/02/15 | 1,020 | 1,021 | 998 | 999 | -16 | -1.6% | 1,296,300 |
2023/02/14 | 1,015 | 1,019 | 1,010 | 1,015 | +7 | +0.7% | 1,486,700 |
2023/02/13 | 1,008 | 1,012 | 1,002 | 1,008 | +6 | +0.6% | 1,272,900 |
2023/02/10 | 994 | 1,003 | 987 | 1,002 | ±0 | ±0% | 1,410,300 |
2023/02/09 | 1,009 | 1,012 | 999 | 1,002 | -12 | -1.2% | 1,785,300 |
2023/02/08 | 987 | 1,015 | 983 | 1,014 | +23 | +2.3% | 2,604,800 |
2023/02/07 | 993 | 995 | 988 | 991 | ±0 | ±0% | 2,282,200 |
2023/02/06 | 995 | 998 | 987 | 991 | +4 | +0.4% | 2,077,900 |
2023/02/03 | 998 | 1,004 | 984 | 987 | -19 | -1.9% | 2,875,900 |
2023/02/02 | 1,007 | 1,012 | 1,003 | 1,006 | -1 | -0.1% | 1,999,700 |
2023/02/01 | 1,011 | 1,017 | 1,007 | 1,007 | -3 | -0.3% | 2,084,200 |
2023/01/31 | 1,014 | 1,019 | 1,005 | 1,010 | +5 | +0.5% | 1,991,900 |
2023/01/30 | 1,000 | 1,012 | 998 | 1,005 | -1 | -0.1% | 3,950,300 |
2023/01/27 | 1,008 | 1,024 | 1,005 | 1,006 | -2 | -0.2% | 3,233,400 |
2023/01/26 | 1,019 | 1,023 | 1,006 | 1,008 | -14 | -1.4% | 2,081,500 |
2023/01/25 | 1,019 | 1,025 | 1,008 | 1,022 | +3 | +0.3% | 1,967,100 |
2023/01/24 | 1,037 | 1,038 | 1,019 | 1,019 | -12 | -1.2% | 1,931,400 |
2023/01/23 | 1,030 | 1,032 | 1,022 | 1,031 | +5 | +0.5% | 1,216,400 |
2023/01/20 | 1,020 | 1,029 | 1,012 | 1,026 | +6 | +0.6% | 1,124,200 |
2023/01/19 | 1,024 | 1,030 | 1,018 | 1,020 | -4 | -0.4% | 812,800 |
2023/01/18 | 1,007 | 1,031 | 1,007 | 1,024 | +18 | +1.8% | 975,500 |
2023/01/17 | 1,000 | 1,009 | 997 | 1,006 | +1 | +0.1% | 1,033,400 |
2023/01/16 | 1,010 | 1,017 | 1,004 | 1,005 | -9 | -0.9% | 986,100 |
2023/01/13 | 1,026 | 1,038 | 1,010 | 1,014 | -23 | -2.2% | 1,443,200 |
2023/01/12 | 1,049 | 1,053 | 1,036 | 1,037 | -4 | -0.4% | 1,012,300 |
2023/01/11 | 1,028 | 1,047 | 1,027 | 1,041 | +24 | +2.4% | 1,993,900 |
2023/01/10 | 1,027 | 1,038 | 1,014 | 1,017 | -9 | -0.9% | 2,446,300 |
2023/01/06 | 1,038 | 1,042 | 1,020 | 1,026 | -4 | -0.4% | 2,009,900 |
501~
550
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 143,100円 | 0.0% | +50.6% | 2.52% | 15.03倍 | 1.69倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 162,800円 | -3.5% | -50.2% | 4.91% | 13.19倍 | 0.98倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 218,000円 | +18.2% | +4.2% | 1.65% | 15.30倍 | 1.95倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 402,500円 | +8.7% | +17.1% | 2.24% | 14.32倍 | 1.07倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 420,100円 | +20.9% | +87.3% | 3.24% | 9.38倍 | 1.08倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム